Product Description: Deulorlatinib (compound A), a deuterated derivative of Lorlatinib (HY-12215), is a potent inhibitor of tyrosine kinase demonstrating the potential for the research of ALK-positive advanced NSCLC[1][2].
Applications: Cancer-Kinase/protease
Formula: C21H16D3FN6O2
References: [1]Shenzhen TargetRx, Inc. Process for preparation of macrocycle. World Intellectual Property Organization, WO2017148325 A1 2017-09-08
CAS Number: 2131126-33-3
Molecular Weight: 409.43
Research Area: Cancer
Target: Others